SSB:
In your opinion, at this point, is it worth it for paracelsian to find a major healthcare/pharmaceutical to buy them out? I mean, someone could get their hands on that signal transduction process and the library of TCM's. I would certaintly think that would be worth at least $2 bucks a share. (ok, maybe thats a little optimistic).
One last thing. I'll get flamed for this. But what if Paracelsian could pursuade Babish to come back? I mean, he could get AndroVir through the FDA, and Alberts could market and handle that side of it. As Paul says, paracelsian could get a "rent a CPA" to handle the books, and Rhodes could look for a permanent CEO replacement.
At this point, I'd give Babish 1 million shares of stock as compensation, hell with dilution. Were already diluted enough. We need somebody big time to get AndroVir and AndroCar on their way. I think babish could do that.
My vote to the company is get babish back. Get him now, spend the money, and hope for the best.
Whatcha think SSB?
Rick D |
